Ask AI
ROS1 in NSCLC
ROS1-Alterations and Molecular Testing in Advanced NSCLC

Released: August 29, 2024

Expiration: August 28, 2025

Activity

In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including:

  • ROS1-gene fusions in advanced lung cancer
  • ROS1 testing recommendations with DNA NGS, RNA NGS, FISH break apart assay, and IHC
  • Comparative specificity of ROS1 and ALK targeting tyrosine kinase inhibitors
  • Advantages of RNA- vs DNA-based next-generation sequencing